Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
This study has been completed.
Study NCT00381862 Information provided by OHSU Knight Cancer Institute
First Received on September 26, 2006. Last Updated on December 12, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Nausea and Vomiting
Additional conditions recognized in this trial
Colorectal Neoplasms
Nausea
Vomiting
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
aprepitant
dexamethasone
fluorouracil
irinotecan hydrochloride
leucovorin calcium
oxaliplatin
palonosetron hydrochloride
quality-of-life assessment
Additional drug interventions recognized in this trial
BB 1101
Camptothecin
Dexamethasone 21-phosphate
Dexamethasone acetate
Irinotecan
Leucovorin
Levoleucovorin
Palonosetron
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antidotes
Antiemetics
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Radiation-Sensitizing Agents
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Vitamin B Complex
Vitamins
Sponsors listed in this trial
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Back to top of Main Content
